PMC:7029759 / 35232-35444 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"937","span":{"begin":165,"end":169},"obj":"Disease"},{"id":"929","span":{"begin":13,"end":17},"obj":"Gene"},{"id":"932","span":{"begin":112,"end":121},"obj":"Species"},{"id":"933","span":{"begin":194,"end":201},"obj":"Species"},{"id":"938","span":{"begin":202,"end":211},"obj":"Disease"}],"attributes":[{"id":"A929","pred":"tao:has_database_id","subj":"929","obj":"Gene:59272"},{"id":"A932","pred":"tao:has_database_id","subj":"932","obj":"Tax:2697049"},{"id":"A933","pred":"tao:has_database_id","subj":"933","obj":"Tax:9606"},{"id":"A937","pred":"tao:has_database_id","subj":"937","obj":"MESH:D012128"},{"id":"A938","pred":"tao:has_database_id","subj":"938","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Essentially, ACE2-Fc could be the potent neutralizing antibody that the global health community needs to combat 2019-nCoV, today, while also treating the underlying ARDS pathophysiology causing patient mortality."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T686","span":{"begin":13,"end":17},"obj":"G_3;PG_10;PR:000003622"},{"id":"T685","span":{"begin":54,"end":62},"obj":"GO:0042571"},{"id":"T684","span":{"begin":112,"end":121},"obj":"SP_7"}],"text":"Essentially, ACE2-Fc could be the potent neutralizing antibody that the global health community needs to combat 2019-nCoV, today, while also treating the underlying ARDS pathophysiology causing patient mortality."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T223","span":{"begin":54,"end":62},"obj":"Body_part"}],"attributes":[{"id":"A223","pred":"fma_id","subj":"T223","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Essentially, ACE2-Fc could be the potent neutralizing antibody that the global health community needs to combat 2019-nCoV, today, while also treating the underlying ARDS pathophysiology causing patient mortality."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T122","span":{"begin":165,"end":169},"obj":"Disease"}],"attributes":[{"id":"A122","pred":"mondo_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"Essentially, ACE2-Fc could be the potent neutralizing antibody that the global health community needs to combat 2019-nCoV, today, while also treating the underlying ARDS pathophysiology causing patient mortality."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T370","span":{"begin":18,"end":20},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"Essentially, ACE2-Fc could be the potent neutralizing antibody that the global health community needs to combat 2019-nCoV, today, while also treating the underlying ARDS pathophysiology causing patient mortality."}

{"project":"LitCovid-sentences","denotations":[{"id":"T219","span":{"begin":0,"end":212},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Essentially, ACE2-Fc could be the potent neutralizing antibody that the global health community needs to combat 2019-nCoV, today, while also treating the underlying ARDS pathophysiology causing patient mortality."}